Induratio penis plastica (IPP) or Peyronie’s disease is an acquired benign connective tissue disorder without known systemic sequelae with presenting symptoms that include the presence of a plaque/induration of the penile shaft, penile curvature or deformity during erection, penile pain, and erectile dysfunction.
Anatomy of peyronie’s disease | Love, C., Katz, D., Chung, E., & Shoshany, O. (2017). Peyronie’s disease – Watch out for the bend. Australian Family Physician, 46, 655–659. Retrieved from http://www.racgp.org.au/afp/2017/september/peyronies-disease/
History
François Gigot de la Peyronie was the first to report a clinical series on penile curvature in 1743. More than 250 years later, the exact aetiology and mechanism of the well-recognized symptom complex still remain unclear.
François Gigot de la Peyronie (1678 – 1747) was a French surgeon eponymously associated with the condition, Peyronie’s disease.
Aetiology
Risk factors:
Acute penile trauma/microtrauma (8-9% cases)
Penile/genital trauma from urologic procedures (e.g. Foley catheterization, cystoscopy, transurethral resection of the prostate, radical prostatectomy)
History of nongonococcal urethritis
History of inflammatory diseases or fibromatous lesions of the genital tract in sexual partner(s)
Smoking
Hypogonadism
Pathophysiology
Anatomy:
Cross section of the penis | Tsambarlis, P., & Levine, L. A. (2019). Nonsurgical management of Peyronie’s disease. Nature Reviews Urology, 16(3), 172–186. https://doi.org/10.1038/s41585-018-0117-7
Peyronie’s disease (PD) is caused by chronic inflammation (progressive fibrosis) of the tunica albuginea (CITA) of the corpora cavernosa resulting in curvature or other deformities of the erect penis.
Proposed pathogenesis of Peyronie’s disease | Tsambarlis, P., & Levine, L. A. (2019). Nonsurgical management of Peyronie’s disease. Nature Reviews Urology, 16(3), 172–186. https://doi.org/10.1038/s41585-018-0117-7
Clinical features
Variable presentation:
Penile curvature (80-91% cases)
Penile shortening (14-60% cases)
Erectile dysfunction (ED) (15-24% cases)
Nodule (15% cases)
Penile pain (3-22% cases)
Penile curvature typical of an advanced stage of Peyronie’s disease | Peyronie – Public Domain, https://commons.wikimedia.org/w/index.php?curid=3687531
This is an example of a patient with congenital (from birth) Peyronie’s disorder due to a malformation in the corpus cavernosum. | SugarMaple – CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=17128004
Diagnosis
Clinical assessment
Diagnosis of curvature of the penis on the apparatus AMVL-01 (apparatus vacuum-laser therapeutic urological) in patient A., 54 years old, with Peyronie’s disease. Local negative pressure with maximum discharge in the flask affects the baro-and thermoreceptors of the skin of the penis, enhances microcirculation in its vessels. An insignificant curvature (angle of curvature – 30 degrees) of the penis | Love, C., Katz, D., Chung, E., & Shoshany, O. (2017). Peyronie’s disease – Watch out for the bend. Australian Family Physician, 46, 655–659. Retrieved from http://www.racgp.org.au/afp/2017/september/peyronies-disease/
Imaging
Ultrasound (USG):
This ultrasound depicts cross sections of the penis at different locations in a patient with Peyronie’s disease. The top image shows normal anatomy whereas the bottom image shows scar tissue on the tunica albuginea (penis). The scar tissue is localized and responsible for the hallmark deformities of Peyronie’s disease (curvature and narrowing). | Angelatomato – CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=23474172
Transverse ultrasound of the penis, in a ventral view, in the middle portion of the penis. Note the echoic image with posterior acoustic shadowing, corresponding to calcification (arrow), in the left corpus cavernosum. | Maitê Aline Vieira Fernandes, Luis Ronan Marquez, Ferreira de Souza and Luciano Pousa Cartafina3 – (2018). “Ultrasound evaluation of the penis”. Radiologia Brasileira 51 (4): 257–261. DOI:10.1590/0100-3984.2016.0152. ISSN 1678-7099.CC-BY license, CC BY 4.0, https://commons.wikimedia.org/w/index.php?curid=77309497
Ultrasound (USG) dopplerography:
Ultrasound dopplerography of the penis of Patient D (36 years old with Peyronie’s disease and venogenic erectile dysfunction): a) in the distal part of the penis, the plaques are from 1–2 to 8.5 mm; b) the dorsal vein did not collapse, and blood flow along it was 30 ml/min. Valsalva test was positive | Love, C., Katz, D., Chung, E., & Shoshany, O. (2017). Peyronie’s disease – Watch out for the bend. Australian Family Physician, 46, 655–659. Retrieved from http://www.racgp.org.au/afp/2017/september/peyronies-disease/
Ultrasound dopplerography of the penis of Patient T (55 years old with Peyronie’s disease and venogenic erectile dysfunction). The patient has Dupuytren’s contracture: a) abnormality of the structure of the cavernous arteries, i.e., anastomosis of the cavernous arteries in the crus of the penis; b) plaques in the cavernous bodies (plaque of 11.4 mm × 4.6 mm × 9.2 mm is marked), which deformed the penis; c) and d) noncollapse concurrence of the dorsal vein as a sign of venous erectile dysfunction | Love, C., Katz, D., Chung, E., & Shoshany, O. (2017). Peyronie’s disease – Watch out for the bend. Australian Family Physician, 46, 655–659. Retrieved from http://www.racgp.org.au/afp/2017/september/peyronies-disease/
X-ray:
Projectional radiography (“X-ray”), penetrating the soft parts of the penis, showing radiopaque images that correspond to calcifications in the corpora cavernosa (arrows). | Maitê Aline Vieira Fernandes, Luis Ronan Marquez, Ferreira de Souza and Luciano Pousa Cartafina3 – (2018). “Ultrasound evaluation of the penis”. Radiologia Brasileira 51 (4): 257–261. DOI:10.1590/0100-3984.2016.0152. ISSN 1678-7099.CC-BY license, CC BY 4.0, https://commons.wikimedia.org/w/index.php?curid=77309499
Vitamin E (antioxidant, inhibits collagen deposition)
Potaba (↓ tissue serotonin levels and scarring)
Colchicine (inhibits collagen synthesis)
Tamoxifen (Modulation of TGF-β1 secretion by fibroblasts → ↓ fibrosis)
Propinyl/acetyl-L-carnitine (inhibits free radicals: ↓Ca2+ in endothelial cells)
Mechanisms of action of oral therapies for Peyronie’s disease | Tsambarlis, P., & Levine, L. A. (2019). Nonsurgical management of Peyronie’s disease. Nature Reviews Urology, 16(3), 172–186. https://doi.org/10.1038/s41585-018-0117-7
Mechanisms of action for topical and intralesional therapies for Peyronie’s disease. | Tsambarlis, P., & Levine, L. A. (2019). Nonsurgical management of Peyronie’s disease. Nature Reviews Urology, 16(3), 172–186. https://doi.org/10.1038/s41585-018-0117-7Demonstration of IFN-α-2b injected directly into a Peyronie’s disease plaque. | Lacy II, G. L., Adams, D. M., & Hellstrom, W. J. G. (2002). Intralesional interferon-alpha-2b for the treatment of Peyronie’s disease. International Journal Of Impotence Research, 14, 336. Retrieved from https://doi.org/10.1038/sj.ijir.3900867
Hyperthermia therapy (modulation of heat shock proteins)
Surgical management:
Tunical albugineal plication (tunical shortening: opposite side of plaque)
Penile plication procedure | Love, C., Katz, D., Chung, E., & Shoshany, O. (2017). Peyronie’s disease – Watch out for the bend. Australian Family Physician, 46, 655–659. Retrieved from http://www.racgp.org.au/afp/2017/september/peyronies-disease/
Plaque incision/excision and grafting (tunical lengthening: side of plaque)
Plaque incision and graft | Love, C., Katz, D., Chung, E., & Shoshany, O. (2017). Peyronie’s disease – Watch out for the bend. Australian Family Physician, 46, 655–659. Retrieved from http://www.racgp.org.au/afp/2017/september/peyronies-disease/
IPP (with possible penile modeling, tunical plication, or plaque incision/excision and grafting)
Mechanical straightening (w/ or w/o plaque manipulation, tunical shortening or lengthening procedures)